Prognostic Indicators for Radiation-induced Breast Fibrosis
NCT05031065 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4
Last updated 2025-06-27
Summary
To study the inflammatory response during and after radiotherapy, especially by measuring the concentration of an enzyme called autotaxin and its product LPA in the blood plasma.
Conditions
Interventions
- RADIATION
-
Breast Cancer Radiotherapy
4000-4250 cGy in 15-16 daily fractions
Sponsors & Collaborators
-
AHS Cancer Control Alberta
lead OTHER
Principal Investigators
-
Zsolt Gabos, MD · AHS-CCI
Eligibility
- Min Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-24
- Primary Completion
- 2025-05-05
- Completion
- 2025-05-05
Countries
- Canada
Study Locations
More Related Trials
-
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
NCT01075607 ·Status: TERMINATED
-
Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
NCT03709186 ·Status: COMPLETED
-
Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis
NCT00610467 ·Status: TERMINATED ·Phase: NA
-
Breast Study to Determine the Ability of Non-Invasive Optical Transillumination Spectroscopy to Predict Breast Density.
NCT00188682 ·Status: COMPLETED
-
Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients
NCT05350722 ·Status: RECRUITING ·Phase: NA
-
Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients
NCT00652678 ·Status: TERMINATED
-
MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
NCT01649661 ·Status: COMPLETED
-
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
NCT00893035 ·Status: COMPLETED
-
Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?
NCT03949946 ·Status: UNKNOWN
-
Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery
NCT01316328 ·Status: COMPLETED
-
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
NCT01004796 ·Status: UNKNOWN
-
Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer Patients
NCT05566613 ·Status: UNKNOWN
-
Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy
NCT00123812 ·Status: WITHDRAWN
-
Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy
NCT01568346 ·Status: TERMINATED ·Phase: PHASE3
-
MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer
NCT03863301 ·Status: WITHDRAWN ·Phase: PHASE2
-
Autoantibodies in Breast Cancer Detection
NCT03623945 ·Status: TERMINATED
-
Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy
NCT00581529 ·Status: TERMINATED ·Phase: PHASE2
-
Angiogenesis in Early Breast Cancer for Prognosis Prediction
NCT00599105 ·Status: COMPLETED ·Phase: NA
-
Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
NCT01027767 ·Status: COMPLETED
-
Effect of Weight Loss on Breast Density Using Digital Mammography and MRI in Women Who Are At Increased Risk For Breast Cancer
NCT01259076 ·Status: TERMINATED
-
Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts
NCT02042456 ·Status: TERMINATED
-
Preoperative Breast Irradiation
NCT02941835 ·Status: TERMINATED ·Phase: NA
-
Breast Lesion Analysis for Tomosynthesis Mammography
NCT00723541 ·Status: COMPLETED ·Phase: NA
-
Improving Characterization of Calcifications With Contrast-Enhanced Mammography
NCT03639129 ·Status: WITHDRAWN ·Phase: NA
-
Visualization Tool for Investigation of Breast Lesions
NCT00934297 ·Status: TERMINATED